Marinomed Biotech Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
36
- Share Price
-
$4.55
- (As of Thursday Closing)
Marinomed Biotech General Information
Description
Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generated from the virology segment.
Contact Information
Website
www.marinomed.comCorporate Office
- Hovengasse 25
- Korneuburg, 2100
- Austria
Corporate Office
- Hovengasse 25
- Korneuburg, 2100
- Austria
Marinomed Biotech Stock Performance
As of 24-Sep-2026, Marinomed Biotech’s stock price is $4.55. Its current market cap is $9.1M with 2M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.55 | $4.58 | $2.75 - $24.19 | $9.1M | 2M | 8.98 | $11.39 |
Marinomed Biotech Financials Summary
As of 31-Dec-2025, Marinomed Biotech has a trailing 12-month revenue of $8.68M.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 52,230 | 52,230 | ||
| Revenue | 8,676 | 8,676 | 5,137 | 9,802 |
| EBITDA | 21,409 | 21,409 | (7,796) | (4,916) |
| Net Income | 20,325 | 20,325 | (16,682) | (6,888) |
| Total Assets | 6,990 | 6,990 | 8,515 | 13,661 |
| Total Debt | 13,394 | 13,394 | 29,376 | 22,543 |
Marinomed Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Marinomed Biotech Comparisons
Industry
Financing
Details
Marinomed Biotech Competitors (8)
One of Marinomed Biotech’s 8 competitors is Bristol-Myers Squibb, a Corporation company based in Princeton, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| VC Cell Therapy | Venture Capital-Backed | Kobe, Japan | ||||
| Mimetogen Pharmaceuticals | Formerly VC-backed | Montreal, Canada | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Nicox | Formerly PE-Backed | Biot, France |
Marinomed Biotech Patents
Marinomed Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4696300-A1 | Aqueous composition comprising fluticasone | Pending | 14-Aug-2024 | ||
| WO-2026037858-A1 | Aqueous composition comprising fluticasone | Pending | 14-Aug-2024 | ||
| WO-2025202347-A1 | Composition comprising iota-carrageenan for use in the treatment of dry eyes, non-viral and non-allergic eye conditions | Pending | 28-Mar-2024 | ||
| EP-4431082-A1 | Aqueous composition comprising budesonide | Inactive | 13-Mar-2023 | ||
| AU-2024236993-A1 | Spraying device comprising aqueous budesonide composition | Pending | 13-Mar-2023 | A61K9/0043 |
Marinomed Biotech Signals
Marinomed Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Marinomed Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Marinomed Biotech FAQs
-
When was Marinomed Biotech founded?
Marinomed Biotech was founded in 2006.
-
Where is Marinomed Biotech headquartered?
Marinomed Biotech is headquartered in Korneuburg, Austria.
-
What is the size of Marinomed Biotech?
Marinomed Biotech has 36 total employees.
-
What industry is Marinomed Biotech in?
Marinomed Biotech’s primary industry is Biotechnology.
-
Is Marinomed Biotech a private or public company?
Marinomed Biotech is a Public company.
-
What is the current stock price of Marinomed Biotech?
As of 24-Sep-2026 the stock price of Marinomed Biotech is $4.55.
-
What is the current market cap of Marinomed Biotech?
The current market capitalization of Marinomed Biotech is $9.1M.
-
What is Marinomed Biotech’s current revenue?
The trailing twelve month revenue for Marinomed Biotech is $8.68M.
-
Who are Marinomed Biotech’s competitors?
Bristol-Myers Squibb, VC Cell Therapy, Mimetogen Pharmaceuticals, Cipla, and Nicox are some of the 8 competitors of Marinomed Biotech.
-
What is Marinomed Biotech’s annual earnings per share (EPS)?
Marinomed Biotech’s EPS for 12 months was $11.39.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process